World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
82
Citations
55648
World Ranking
15836
National Ranking
7968

Overview

Eleftherios P. Mamounas is affiliated with University of Florida Health in the United States and has a research focus primarily within medicine and biochemistry, genetics, and molecular biology. Their scholarly contributions span multiple subfields including cancer research, oncology, pulmonary and respiratory medicine, genetics, and radiology, nuclear medicine, and imaging.

The scientist's work centers notably on breast cancer, contributing extensively to studies involving breast cancer treatment and advanced therapies, HER2/EGFR pathways in cancer research, cancer treatment and pharmacology, BRCA gene mutations, estrogen and related hormone effects, and cancer genomics and diagnostics.

Frequent venues for publication include:

  • Journal of Clinical Oncology
  • Cancer Research
  • Clinical Cancer Research
  • Annals of Surgical Oncology
  • Clinical Breast Cancer

Significant recent papers by Eleftherios P. Mamounas include:

  • "Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13,864 women in seven randomised trials," published in 2021 in The Lancet Oncology
  • "Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study," published in 2021 in The Lancet Oncology
  • "Management of Cancer Surgery Cases During the COVID-19 Pandemic: Considerations," published in 2020 in Annals of Surgical Oncology
  • "NRG-BR002: A phase IIR/III trial of standard of care systemic therapy with or without stereotactic body radiotherapy (SBRT) and/or surgical resection (SR) for newly oligometastatic breast cancer (NCT02364557)," published in 2022 in Journal of Clinical Oncology
  • "Radiotherapy to regional nodes in early breast cancer: an individual patient data meta-analysis of 14,324 women in 16 trials," published in 2023 in The Lancet

Collaborations are notable with frequent co-authors such as Norman Wolmark, Charles E. Geyer, Priya Rastogi, Reena S. Cecchini, and Hanna Bandos, reflecting a strong network in oncology and breast cancer research.

The body of work conducted by Eleftherios P. Mamounas encompasses a significant number of contributions in cancer treatment studies, reflecting a deep engagement with clinical and translational research that addresses therapeutic strategies, patient management, and outcomes in oncology. Their publications establish a substantive presence in top-tier journals, emphasizing ongoing contributions to evidence-based practices in cancer care.

Best Publications

  • Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

    Edward H. Romond;Edith A. Perez;John Bryant;Vera J. Suman

  • Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis

    Patricia Cortazar;Lijun Zhang;Michael Untch;Keyur Mehta

  • Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.

    B Fisher;J Bryant;N Wolmark;E Mamounas

  • Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18.

    B Fisher;A Brown;E Mamounas;S Wieand

  • Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial

    David N. Krag;Stewart J. Anderson;Thomas B. Julian;Ann M. Brown

  • Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer

    Gunter Von Minckwitz;Chiun Sheng Huang;Max S. Mano;Sibylle Loibl

  • Preoperative Chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27

    Priya Rastogi;Stewart J. Anderson;Harry D. Bear;Charles E. Geyer

  • American Society of Clinical Oncology Technology Assessment on the Use of Aromatase Inhibitors As Adjuvant Therapy for Postmenopausal Women With Hormone Receptor–Positive Breast Cancer: Status Report 2004

    Eric P. Winer;Clifford Hudis;Harold J. Burstein;Antonio C. Wolff

  • Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial

    Bernard Fisher;James Dignam;Norman Wolmark;D Lawrence Wickerham

  • Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer : National surgical adjuvant breast and bowel project protocol B-27

    Harry D. Bear;Stewart Anderson;Roy E. Smith;Charles E. Geyer

  • Assessment of Cardiac Dysfunction in a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel, With or Without Trastuzumab As Adjuvant Therapy in Node-Positive, Human Epidermal Growth Factor Receptor 2-Overexpressing Breast Cancer: NSABP B-31

    Elizabeth Tan-Chiu;Greg Yothers;Edward Romond;Charles E. Geyer

  • Trastuzumab Plus Adjuvant Chemotherapy for Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Planned Joint Analysis of Overall Survival From NSABP B-31 and NCCTG N9831

    Edith A. Perez;Edward H. Romond;Vera J. Suman;Jong Hyeon Jeong

  • The Benefit of Leucovorin-Modulated Fluorouracil as Postoperative Adjuvant Therapy for Primary Colon Cancer: Results From National Surgical Adjuvant Breast and Bowel Project Protocol C-03

    N Wolmark;H Rockette;B Fisher;D L Wickerham

  • Four-Year Follow-Up of Trastuzumab Plus Adjuvant Chemotherapy for Operable Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Joint Analysis of Data From NCCTG N9831 and NSABP B-31

    Edith A. Perez;Edward H. Romond;Vera J. Suman;Jong Hyeon Jeong

  • Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

    Bernard Asselain;William Barlow;John Bartlett;Jonas Bergh

  • Long-Term Outcomes of Invasive Ipsilateral Breast Tumor Recurrences After Lumpectomy in NSABP B-17 and B-24 Randomized Clinical Trials for DCIS

    Irene L. Wapnir;James J. Dignam;Bernard Fisher;Eleftherios P. Mamounas

  • Significance of ipsilateral breast tumour recurrence after lumpectomy.

    B Fisher;S Anderson;E.R Fisher;C Redmond

  • Association Between the 21-Gene Recurrence Score Assay and Risk of Locoregional Recurrence in Node-Negative, Estrogen Receptor–Positive Breast Cancer: Results From NSABP B-14 and NSABP B-20

    Eleftherios P. Mamounas;Gong Tang;Bernard Fisher;Soonmyung Paik

  • Comparative Efficacy of Adjuvant Chemotherapy in Patients With Dukes' B Versus Dukes' C Colon Cancer: Results From Four National Surgical Adjuvant Breast and Bowel Project Adjuvant Studies (C-01, C-02, C-03, and C-04)

    Eleftherios Mamounas;Samuel Wieand;Norman Wolmark;Harry D. Bear

  • Bevacizumab added to neoadjuvant chemotherapy for breast cancer

    Harry D. Bear;Gong Tang;Priya Rastogi;Charles E. Geyer

Frequent Co-Authors

Norman Wolmark
Norman Wolmark University of Pittsburgh
Joseph P. Costantino
Joseph P. Costantino University of Pittsburgh
Sandra M. Swain
Sandra M. Swain Georgetown University Medical Center
Soonmyung Paik
Soonmyung Paik Yonsei University
Louis Fehrenbacher
Louis Fehrenbacher Kaiser Permanente
Bernard Fisher
Bernard Fisher University of Pittsburgh
Patricia A. Ganz
Patricia A. Ganz University of California, Los Angeles
Adam Brufsky
Adam Brufsky University of Pittsburgh
Charles E. Geyer
Charles E. Geyer University of Pittsburgh
Edwin R. Fisher
Edwin R. Fisher University of Pittsburgh

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine doesn’t always follow a single straight path. Today, there are various online degrees that complement or provide alternatives to traditional medical education in the USA.

For those interested in preventative care, an online degree nutrition program offers flexible learning to build expertise in dietetics and wellness—a vital area as patient care expands beyond hospitals.

If you’re passionate about management and leadership in healthcare, explore the best online mha programs. These are designed for professionals seeking to move into administrative roles within healthcare organizations.

Practicing nurses can now broaden their qualifications through rn bsn online programs no clinicals, which make achieving a BSN easier for those balancing work and study.

Advanced nursing careers are also supported by accredited dnp online programs. These streamline the process of earning a Doctor of Nursing Practice degree, opening leadership and specialist roles.

Whether you’re shifting focus or seeking advancement, these pathways demonstrate the diverse, flexible options available in modern medical education.

Best Scientists Citing Eleftherios P. Mamounas

Trending Scientists